{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:23:00Z","timestamp":1794288180005,"version":"4.9.0"},"reference-count":253,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP220103091"],"award-info":[{"award-number":["DP220103091"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000927","name":"Prostate Cancer Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2025.217441","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:16:23Z","timestamp":1736021783000},"page":"217441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer"],"prefix":"10.1016","volume":"611","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8117-5672","authenticated-orcid":false,"given":"Madison T.","family":"Hindes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"McElligott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Selemidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bukuru D.","family":"Nturubika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane M.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Thurgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-3626","authenticated-orcid":false,"given":"Douglas A.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-024-00482-x","article-title":"Cancer metabolism and carcinogenesis","volume":"13","author":"Yang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and implications of metabolic heterogeneity in cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metabol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217441_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/ars.2016.6750","article-title":"Heterogeneity in cancer metabolism: new concepts in an old field","volume":"26","author":"Gentric","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.canlet.2025.217441_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.840616","article-title":"Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study","volume":"12","author":"Ou","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics16010055","article-title":"Treatment of chronic lymphocytic leukemia in the personalized medicine era","volume":"16","author":"S\u00e1nchez Su\u00e1rez","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic plasticity in CLL: adaptation to the hypoxic niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-022-00292-z","article-title":"Targeting metabolic reprogramming in chronic lymphocytic leukemia","volume":"11","author":"Nie","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41375-020-0797-x","article-title":"Richter transformation in chronic lymphocytic leukemia (CLL)\u2014a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials","volume":"35","author":"Al-Sawaf","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib13","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00277-021-04603-y","article-title":"Outcomes of Richter's transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL): an analysis of the SEER database","volume":"100","author":"Elnair","year":"2021","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/PPO.0b013e31826cda2d","article-title":"Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?","volume":"18","author":"Santos","year":"2012","journal-title":"Cancer J."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2014.12.013","article-title":"The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy","volume":"94","author":"Trendowski","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2025.217441_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.exphem.2021.12.193","article-title":"Lipid uptake in chronic lymphocytic leukemia","volume":"106","author":"Thurgood","year":"2022","journal-title":"Exp. Hematol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217441_bib17","first-page":"1267","article-title":"Detection of Richters transformation of chronic lymphocytic leukemia by PET\/CT","volume":"47","author":"Bruzzi","year":"2006","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12938-021-00973-6","article-title":"The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019","volume":"21","author":"Yao","year":"2022","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.canlet.2025.217441_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102307","article-title":"Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY","volume":"65","author":"Chatzikonstantinou","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.canlet.2025.217441_bib20","unstructured":"Cancer data in Australia. In: Australian Institute of Health and Welfare, Canberra. Last updated: 24\/08\/2023. Available from: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia."},{"issue":"49","key":"10.1016\/j.canlet.2025.217441_bib21","doi-asserted-by":"crossref","first-page":"84902","DOI":"10.18632\/oncotarget.17926","article-title":"Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer","volume":"8","author":"Al Kadhi","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ecl.2011.05.012","article-title":"Overview of prostate anatomy, histology and pathology","volume":"40","author":"Lee","year":"2011","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-5-17","article-title":"The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots","volume":"5","author":"Costello","year":"2006","journal-title":"Mol. Cancer"},{"issue":"46","key":"10.1016\/j.canlet.2025.217441_bib24","doi-asserted-by":"crossref","first-page":"28875","DOI":"10.1074\/jbc.272.46.28875","article-title":"Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells","volume":"272","author":"Costello","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib25","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.3390\/cancers12113339","article-title":"Modulation of de novo lipogenesis improves response to enzalutamide treatment in prostate cancer","volume":"12","author":"Lounis","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.pcan.4500879","article-title":"Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer","volume":"9","author":"Liu","year":"2006","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000012183","article-title":"The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy","volume":"59","author":"Costello","year":"2000","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-5347(01)66366-3","article-title":"Metabolic imaging of untreated prostate cancer by positron emission tomography with sup 18 fluorine-labeled deoxyglucose","volume":"155","author":"Effert","year":"1996","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib29","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajur.2019.12.003","article-title":"Lipogenic effects of androgen signaling in normal and malignant prostate","volume":"7","author":"Mah","year":"2020","journal-title":"Asian Journal of Urology"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib32","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/aja.2011.164","article-title":"The prostate cancer bone marrow niche: more than just \u2018fertile soil\u2019","volume":"14","author":"Pedersen","year":"2012","journal-title":"Asian J. Androl."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib34","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217441_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.phrs.2018.02.022","article-title":"Lipid pathway deregulation in advanced prostate cancer","volume":"131","author":"Galbraith","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40347-7","article-title":"Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression","volume":"13","author":"Lazniewska","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.2021013990","article-title":"Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment","volume":"140","author":"Chen","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.canlet.2025.217441_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316893","article-title":"Crosstalk between endothelial cells and tumor cells: a new era in prostate cancer progression","volume":"24","author":"Ji","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.canlet.2025.217441_bib39","doi-asserted-by":"crossref","first-page":"64854","DOI":"10.18632\/oncotarget.11712","article-title":"Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1\u03b1 activation","volume":"7","author":"Diedrich","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.canlet.2025.217441_bib40","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/cancers14092083","article-title":"Bone progenitors pull the strings on the early metabolic rewiring occurring in prostate cancer cells","volume":"14","author":"Sanchis","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-410X.2003.04218.x","article-title":"Prostate cancer cell growth is modulated by adipocyte\u2010cancer cell interaction","volume":"91","author":"Tokuda","year":"2003","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib42","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: a meta\u2010analysis of cohort studies","volume":"122","author":"Larsson","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"45","key":"10.1016\/j.canlet.2025.217441_bib43","article-title":"The impact of body mass index on prostate cancer: an updated systematic review and meta-analysis","volume":"101","author":"Tzenios","year":"2022","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/medicina59020289","article-title":"Associations between body mass index and prostate cancer: the impact on progression-free survival","volume":"59","author":"Popovici","year":"2023","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib45","article-title":"Associations between body mass index and prostate cancer: the impact on progression-free survival","volume":"59","author":"Popovici","year":"2023","journal-title":"Medicina [Internet]"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer\u2013specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib47","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/BF01249629","article-title":"Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose","volume":"23","author":"Rigo","year":"1996","journal-title":"Eur. J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1148\/rg.2016150073","article-title":"Malignancies with low fluorodeoxyglucose uptake at PET\/CT: pitfalls and prognostic importance","volume":"36","author":"Flavell","year":"2016","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjh.15751","article-title":"Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis","volume":"185","author":"Thurgood","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"85","key":"10.1016\/j.canlet.2025.217441_bib50","doi-asserted-by":"crossref","first-page":"35541","DOI":"10.18632\/oncotarget.26222","article-title":"Lipid profiles of prostate cancer cells","volume":"9","author":"Sorvina","year":"2018","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.canlet.2025.217441_bib51","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1158\/0008-5472.CAN-20-3863","article-title":"Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition","volume":"81","author":"Butler","year":"2021","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046456","article-title":"The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy","volume":"7","author":"Nieva","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-021-01476-y","article-title":"Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis","volume":"20","author":"Bai","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/00037028231182721","article-title":"Distinct lipid phenotype of cancer-associated fibroblasts (CAFs) isolated from overweight\/obese endometrial cancer patients as assessed using Raman spectroscopy","volume":"77","author":"Yeu","year":"2023","journal-title":"Appl. Spectrosc."},{"issue":"20","key":"10.1016\/j.canlet.2025.217441_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166644","article-title":"Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma","volume":"133","author":"Huang","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"6009","key":"10.1016\/j.canlet.2025.217441_bib56","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217441_bib57","series-title":"The Heterogeneity of Cancer Metabolism","first-page":"149","article-title":"The intratumoral heterogeneity of cancer metabolism","author":"Nabi","year":"2021"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11738-0","article-title":"Metabolic landscape of the tumor microenvironment at single cell resolution","volume":"10","author":"Xiao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217441_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.735463","article-title":"Metabolic program of regulatory B lymphocytes and influence in the control of malignant and autoimmune situations","volume":"12","author":"Iperi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217441_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2018.09.019","article-title":"From zero to sixty and back to zero again: the metabolic life of B cells","volume":"57","author":"Akkaya","year":"2019","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","article-title":"Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis","volume":"21","author":"Weisel","year":"2020","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41590-022-01376-y","article-title":"SREBP signaling is essential for effective B cell responses","volume":"24","author":"Luo","year":"2023","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib63","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41590-021-00936-y","article-title":"Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation","volume":"22","author":"Chen","year":"2021","journal-title":"Nat. Immunol."},{"issue":"6427","key":"10.1016\/j.canlet.2025.217441_bib64","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.aav0173","article-title":"Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation","volume":"363","author":"Lee","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib65","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"Lebien","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2025.217441_bib66","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","article-title":"The chemokine receptor CCR7 and \u03b14 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes","volume":"99","author":"Till","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.20020201","article-title":"Chemokine requirements for B cell entry to lymph nodes and Peyer's patches","volume":"196","author":"Okada","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00868-1","article-title":"Reprogramming of sentinel lymph node microenvironment during tumor metastasis","volume":"29","author":"Li","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2025.217441_bib69","series-title":"Metabolic Control","first-page":"321","article-title":"Organ-specific cancer metabolism and its potential for therapy","author":"Elia","year":"2015"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsbmb.2004.10.013","article-title":"Androgens, lipogenesis and prostate cancer","volume":"92","author":"Swinnen","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.pcan.4500712","article-title":"Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve","volume":"7","author":"Costello","year":"2004","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib72","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","article-title":"Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread","volume":"12","author":"McNeal","year":"1988","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.2990020105","article-title":"The zonal anatomy of the prostate","volume":"2","author":"McNeal","year":"1981","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib74","first-page":"313","article-title":"The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?","volume":"5","author":"Adler","year":"2012","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib75","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1464-410X.2006.06427.x","article-title":"Gene expression profiling of the human prostate zones","volume":"98","author":"Van Der Heul\u2010Nieuwenhuijsen","year":"2006","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.pcan.4500997","article-title":"Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland","volume":"11","author":"Noel","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"16","key":"10.1016\/j.canlet.2025.217441_bib77","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood.2023019609","article-title":"Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis","volume":"142","author":"Kolijn","year":"2023","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.canlet.2025.217441_bib78","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.canlet.2025.217441_bib79","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1182\/bloodadvances.2023011384","article-title":"TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era","volume":"7","author":"Landsburg","year":"2023","journal-title":"Blood Advances"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13827","article-title":"Prognostic value of genomic mutations in metastatic prostate cancer","volume":"9","author":"Zhu","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","article-title":"Inherited TP53 variants and risk of prostate cancer","volume":"81","author":"Maxwell","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.217441_bib82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molmet.2019.10.002","article-title":"Metabolic functions of the tumor suppressor p53: implications in normal physiology, metabolic disorders, and cancer","volume":"33","author":"Lacroix","year":"2020","journal-title":"Mol. Metabol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib83","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","article-title":"The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression","volume":"64","author":"Schwartzenberg-Bar-Yoseph","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-\u03baB pathway and inhibits cell transformation","volume":"10","author":"Kawauchi","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib85","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/emboj.2010.330","article-title":"ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair","volume":"30","author":"Cosentino","year":"2011","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib86","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.celrep.2015.04.014","article-title":"ATM couples replication stress and metabolic reprogramming during cellular senescence","volume":"11","author":"Aird","year":"2015","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib87","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1535-7163.MCT-18-0804","article-title":"Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate cancer cells to antiandrogen therapies","volume":"18","author":"Rice","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.3758","article-title":"Notch controls the survival of memory CD4+ T cells by regulating glucose uptake","volume":"21","author":"Maekawa","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217441_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00575","article-title":"Notch signaling regulates mitochondrial metabolism and NF-\u03baB activity in triple-negative breast cancer cells via IKK\u03b1-dependent non-canonical pathways","volume":"8","author":"Hossain","year":"2018","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib90","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.canlet.2025.217441_bib91","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/cancers14092113","article-title":"Glycolysis dependency as a hallmark of SF3B1-mutated cells","volume":"14","author":"Vivet-Noguer","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.canlet.2025.217441_bib92","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3324\/haematol.2018.203067","article-title":"Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity","volume":"104","author":"Lu","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib93","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/leu.2009.295","article-title":"Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups","volume":"24","author":"Macintyre","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib94","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3324\/haematol.2013.101378","article-title":"The clinical significance of patients' sex in chronic lymphocytic leukemia","volume":"99","author":"Catovsky","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib95","doi-asserted-by":"crossref","DOI":"10.4081\/hr.2013.e4","article-title":"Male-to-female sex ratios of abnormalities detected by fluorescence in situ hybridization in a population of chronic lymphocytic leukemia patients","volume":"5","author":"Cant\u00fa","year":"2013","journal-title":"Hematol. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib97","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/10428194.2015.1106533","article-title":"Metabolism pathways in chronic lymphocytic leukemia","volume":"57","author":"Rozovski","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib98","article-title":"Targeting lipid metabolism in cancer metastasis","volume":"1879","author":"Pascual","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib99","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"issue":"478","key":"10.1016\/j.canlet.2025.217441_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5758","article-title":"Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer","volume":"11","author":"Watt","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"30","key":"10.1016\/j.canlet.2025.217441_bib101","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.18632\/oncotarget.25066","article-title":"STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells","volume":"9","author":"Rozovski","year":"2018","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.canlet.2025.217441_bib102","doi-asserted-by":"crossref","first-page":"22324","DOI":"10.18632\/oncotarget.8078","article-title":"To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients","volume":"7","author":"Piszcz","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib103","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.bbadis.2014.07.016","article-title":"The arachidonic acid\u2013LTB4\u2013BLT2 pathway enhances human B-CLL aggressiveness","volume":"1842","author":"Guriec","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1442","article-title":"Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival","volume":"13","author":"Nguyen Van Long","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"30","key":"10.1016\/j.canlet.2025.217441_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","article-title":"Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs","volume":"30","author":"Cyster","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"17","key":"10.1016\/j.canlet.2025.217441_bib106","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1182\/blood-2013-10-532200","article-title":"Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia","volume":"123","author":"Jitschin","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib107","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1541-7786.MCR-17-0026","article-title":"B-cell receptor signaling regulates metabolism in chronic lymphocytic leukemia","volume":"15","author":"Vangapandu","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib108","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1541-7786.MCR-14-0412","article-title":"Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells","volume":"13","author":"Rozovski","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib109","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.leu.2405058","article-title":"Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells","volume":"22","author":"Pallasch","year":"2008","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib110","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib111","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.canlet.2025.217441_bib112","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib113","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"Heintel","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217441_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00411","article-title":"Ibrutinib resistance is reduced by an inhibitor of fatty acid oxidation in primary CLL lymphocytes","volume":"8","author":"Galicia-V\u00e1zquez","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies","volume":"36","author":"Gui\u00e8ze","year":"2019","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.canlet.2025.217441_bib116","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3324\/haematol.2019.222588","article-title":"Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia","volume":"104","author":"Tausch","year":"2019","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.canlet.2025.217441_bib117","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1182\/blood.2021014304","article-title":"Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies","volume":"140","author":"Thomalla","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib118","first-page":"369","article-title":"Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach","volume":"30","author":"Liu","year":"2010","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.canlet.2025.217441_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodr\u00edguez","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib121","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"issue":"7635","key":"10.1016\/j.canlet.2025.217441_bib122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib123","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.4271","article-title":"Syndecan\u20101 (CD138) contributes to prostate cancer progression by stabilizing tumour\u2010initiating cells","volume":"231","author":"Shimada","year":"2013","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3","article-title":"Selective activation of the fatty acid synthesis pathway in human prostate cancer","volume":"88","author":"Swinnen","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.10127","article-title":"Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer","volume":"98","author":"Swinnen","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib126","first-page":"707","article-title":"Fatty acid synthase expression defines distinct molecular signatures in prostate cancer","volume":"1","author":"Rossi","year":"2003","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib127","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.tcb.2017.07.006","article-title":"Emerging roles for the lysosome in lipid metabolism","volume":"27","author":"Thelen","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-3002-1-3","article-title":"Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth","volume":"1","author":"Griffiths","year":"2013","journal-title":"Cancer Metabol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1541-7786.MCR-11-0206","article-title":"Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells","volume":"10","author":"Huang","year":"2012","journal-title":"Mol. Cancer Res."},{"issue":"21","key":"10.1016\/j.canlet.2025.217441_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113029","article-title":"The gene expression landscape of prostate cancer BM reveals close interaction with the bone microenvironment","volume":"23","author":"Saraji","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib132","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ijc.30903","article-title":"A distinct plasma lipid signature associated with poor prognosis in castration\u2010resistant prostate cancer","volume":"141","author":"Lin","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib133","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41391-021-00338-z","article-title":"Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer","volume":"24","author":"Lin","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib134","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/metabo13070799","article-title":"The role of cholesterol in chronic lymphocytic leukemia development and pathogenesis","volume":"13","author":"White","year":"2023","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428194.2015.1088651","article-title":"A link between hypercholesterolemia and chronic lymphocytic leukemia","volume":"57","author":"Chow","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2025.217441_bib136","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ebiom.2016.11.033","article-title":"Low density lipoproteins amplify cytokine-signaling in chronic lymphocytic leukemia cells","volume":"15","author":"McCaw","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib137","first-page":"23","article-title":"Cholesterol homeostasis in isolated lymphocytes: a differential correlation between male controls and chronic lymphocytic leukemia subjects","volume":"18","author":"Sankanagoudar","year":"2017","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib138","first-page":"831","article-title":"Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol","volume":"59","author":"Hardwick","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217441_bib139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ebiom.2016.12.001","article-title":"Lipids and their effects in chronic lymphocytic leukemia","volume":"15","author":"Friedman","year":"2017","journal-title":"EBioMedicine"},{"issue":"20","key":"10.1016\/j.canlet.2025.217441_bib140","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/s41388-022-02276-z","article-title":"Fatty acid oxidation enzyme \u03943, \u03942-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients","volume":"41","author":"Bramhecha","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217441_bib141","series-title":"CPT1a Regulates the Delivery of Extracellular Fatty Acids for Cardiolipin Turnover in Prostate Cancer Cells","author":"Santiappillai","year":"2024"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib142","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1158\/0008-5472.CAN-20-2511","article-title":"ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer","volume":"81","author":"Centenera","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217441_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149273","article-title":"Fatty acid elongation regulates mitochondrial \u03b2-oxidation and cell viability in prostate cancer by controlling malonyl-CoA levels","volume":"691","author":"Scott","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217441_bib144","article-title":"Acetyl-CoA carboxylases and diseases","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.euf.2018.03.008","article-title":"Increased prostate cancer glucose metabolism detected by 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in localised Gleason 8\u201310 prostate cancers identifies very high\u2013risk patients for early recurrence and resistance to castration","volume":"5","author":"Lavall\u00e9e","year":"2019","journal-title":"European Urology Focus"},{"issue":"5516","key":"10.1016\/j.canlet.2025.217441_bib146","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1126\/science.1058079","article-title":"Cooperation and competition in the evolution of ATP-producing pathways","volume":"292","author":"Pfeiffer","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217441_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00324","article-title":"Oxygen levels and immunological studies","volume":"8","author":"Zenewicz","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217441_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib149","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11899-014-0223-4","article-title":"Risk factors for Richter syndrome in chronic lymphocytic leukemia","volume":"9","author":"Parikh","year":"2014","journal-title":"Curr Hematol Malig Rep."},{"issue":"43","key":"10.1016\/j.canlet.2025.217441_bib150","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_390804","article-title":"Practical management of Richter transformation in 2023 and beyond","author":"Ryan","year":"2023","journal-title":"American Society of Clinical Oncology Educational Book"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib151","doi-asserted-by":"crossref","first-page":"525","DOI":"10.6004\/jadpro.2022.13.5.6","article-title":"Richter transformation: clinical manifestations, evaluation, and management","volume":"13","author":"Douglas","year":"2022","journal-title":"Journal of the Advanced Practitioner in Oncology"},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib152","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000722","article-title":"B-cell receptor signaling induced metabolic alterations in chronic lymphocytic leukemia can be partially bypassed by TP53 abnormalities","volume":"6","author":"Kluckova","year":"2022","journal-title":"HemaSphere"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib153","article-title":"HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1\/2 signaling pathway","volume":"18","author":"Zhao","year":"2023","journal-title":"Open Life Sci."},{"key":"10.1016\/j.canlet.2025.217441_bib154","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/OTT.S338826","article-title":"Expression and prognostic value of glucose transporter 3 in diffuse large B cell lymphoma","volume":"15","author":"Xu","year":"2022","journal-title":"OncoTargets Ther."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.2020005734","article-title":"Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1","volume":"137","author":"Kohlhaas","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib156","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1200\/JCO.1993.11.10.1985","article-title":"Richter's syndrome: a report on 39 patients","volume":"11","author":"Robertson","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217441_bib157","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2020.05.007","article-title":"GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers","volume":"485","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217441_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.680928","article-title":"Expression and clinical significance of HKII and HIF-1\u03b1 in grade groups of prostate cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib159","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/diagnostics12030676","article-title":"GLUT3\/SLC2A3 Is an endogenous marker of hypoxia in prostate cancer cell lines and patient-derived xenograft tumors","volume":"12","author":"Ryniawec","year":"2022","journal-title":"Diagnostics"},{"issue":"13","key":"10.1016\/j.canlet.2025.217441_bib160","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3390\/cancers15133473","article-title":"Lactate as key metabolite in prostate cancer progression: what are the clinical implications?","volume":"15","author":"Chetta","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib161","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1039\/C5MB00413F","article-title":"Epithelial-to-mesenchymal transition involves triacylglycerol accumulation in DU145 prostate cancer cells","volume":"11","author":"Dalmau","year":"2015","journal-title":"Mol. Biosyst."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib162","doi-asserted-by":"crossref","first-page":"130","DOI":"10.18632\/oncotarget.2766","article-title":"Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells","volume":"6","author":"Shiraishi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217441_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"39","key":"10.1016\/j.canlet.2025.217441_bib164","doi-asserted-by":"crossref","first-page":"65143","DOI":"10.18632\/oncotarget.17821","article-title":"CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.canlet.2025.217441_bib165","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1158\/0008-5472.CAN-04-0389","article-title":"CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells","volume":"64","author":"Draffin","year":"2004","journal-title":"Cancer Res."},{"issue":"7_Supplement","key":"10.1016\/j.canlet.2025.217441_bib166","first-page":"770","article-title":"CD44 expression correlates with adhesion of prostate and breast cancer cells to the bone marrow endothelium","volume":"64","author":"Draffin","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217441_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114168","article-title":"STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions","volume":"158","author":"Sadrkhanloo","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib168","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/01635581.2020.1792946","article-title":"Leptin promotes prostate cancer proliferation and migration by stimulating STAT3 pathway","volume":"73","author":"Gorrab","year":"2021","journal-title":"Nutr. Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2025.217441_bib169","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/cam4.3082","article-title":"Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness","volume":"9","author":"Kamel","year":"2020","journal-title":"Cancer Med."},{"issue":"43","key":"10.1016\/j.canlet.2025.217441_bib170","doi-asserted-by":"crossref","first-page":"42660","DOI":"10.1074\/jbc.M304984200","article-title":"Prostate cancer cell-adipocyte interaction","volume":"278","author":"Onuma","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib171","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jss.2004.01.017","article-title":"Prostate cancer cell proliferation is influenced by leptin","volume":"118","author":"Somasundar","year":"2004","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.canlet.2025.217441_bib172","series-title":"Cancer Data in Australia [Internet]","year":"2023"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib173","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2019.224121","article-title":"Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib174","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bco2.116","article-title":"Mortality in men with castration\u2010resistant prostate cancer\u2014a long\u2010term follow\u2010up of a population\u2010based real\u2010world cohort","volume":"3","author":"Khoshkar","year":"2022","journal-title":"BJUI Compass"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41391-023-00725-8","article-title":"Real-world treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population","volume":"27","author":"Freedland","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2025.217441_bib176","series-title":"Cancer Treat Res","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-93339-9_4","article-title":"Liquid biopsy in prostate cancer: circulating tumor cells and beyond","author":"Zainfeld","year":"2018"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib177","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/1471-2407-12-540","article-title":"Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy","volume":"12","author":"Mitra","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib178","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0789-0","article-title":"Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer","volume":"37","author":"Chen","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib179","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.canlet.2025.217441_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417422","article-title":"The role of tumor metabolic reprogramming in tumor immunity","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib181","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neo.2017.07.004","article-title":"The stromal microenvironment modulates mitochondrial oxidative phosphorylation in chronic lymphocytic leukemia cells","volume":"19","author":"Vangapandu","year":"2017","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.canlet.2025.217441_bib182","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf9096","article-title":"Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival","volume":"8","author":"Whitburn","year":"2022","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib183","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.18632\/oncotarget.1482","article-title":"Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms","volume":"4","author":"Herroon","year":"2013","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib184","first-page":"1706","article-title":"Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues","volume":"7","author":"Das","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib185","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2684::AID-CNCR13>3.0.CO;2-V","article-title":"The American college of surgeons commission on cancer and the American cancer society. The national cancer data base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia","volume":"86","author":"Diehl","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib186","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jmri.23619","article-title":"Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects","volume":"36","author":"Griffith","year":"2012","journal-title":"J. Magn. Reson. Imag."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib187","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib188","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2025.217441_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02970","article-title":"Coexpression of CCR7 and CXCR4 during B cell development controls CXCR4 responsiveness and bone marrow homing","volume":"10","author":"McHeik","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217441_bib190","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/db15-1689","article-title":"CCR7 maintains nonresolving lymph node and adipose inflammation in obesity","volume":"65","author":"Hellmann","year":"2016","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib191","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10522","article-title":"Expression of CXCR4 and CXCL12 (SDF\u20101) in human prostate cancers (PCa) in vivo","volume":"89","author":"Sun","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib192","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00223-017-0350-8","article-title":"Bone marrow microenvironment as a regulator and therapeutic target for prostate cancer bone metastasis","volume":"102","author":"Park","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib193","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib194","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2025.217441_bib195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2020.06.004","article-title":"Hypoxia in bone metastasis and osteolysis","volume":"489","author":"Todd","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217441_bib196","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bonekey.2015.58","article-title":"Acidic microenvironment and bone pain in cancer-colonized bone","volume":"4","author":"Yoneda","year":"2015","journal-title":"BoneKEy Rep."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib197","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jbo.2016.06.004","article-title":"The role of extracellular calcium in bone metastasis","volume":"5","author":"Breuksch","year":"2016","journal-title":"Journal of Bone Oncology"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib198","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcb.21835","article-title":"Annexin II\/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer","volume":"105","author":"Shiozawa","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib199","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1055-9965.EPI-07-2747","article-title":"Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases","volume":"17","author":"Schwartz","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/fon.12.76","article-title":"The multifaceted actions of PTHrP in skeletal metastasis","volume":"8","author":"Soki","year":"2012","journal-title":"Future Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib201","doi-asserted-by":"crossref","first-page":"R294","DOI":"10.1530\/EC-18-0283","article-title":"Circulating vitamin D level and mortality in prostate cancer patients: a dose\u2013response meta-analysis","volume":"7","author":"Song","year":"2018","journal-title":"Endocrine Connections"},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib202","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3324\/haematol.2019.231456","article-title":"Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNF\u03b1, IL-6 and IL-11 cytokines","volume":"106","author":"Giannoni","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-013-9626-1","article-title":"Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies","volume":"31","author":"Hagberg Thulin","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"41","key":"10.1016\/j.canlet.2025.217441_bib204","doi-asserted-by":"crossref","first-page":"39548","DOI":"10.1074\/jbc.M300539200","article-title":"Vascular endothelial growth factor up-regulates expression of receptor activator of NF-\u03baB (RANK) in endothelial cells","volume":"278","author":"Min","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcp.20547","article-title":"Role of the RANKL\/RANK system in the induction of interleukin\u20108 (IL\u20108) in B chronic lymphocytic leukemia (B\u2010CLL) cells","volume":"207","author":"Secchiero","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib206","article-title":"RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib207","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/0008-5472.CAN-12-2280","article-title":"RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia","volume":"73","author":"Schmiedel","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217441_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1184463","article-title":"Metabolic regulation by biomaterials in osteoblast","volume":"11","author":"Kang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.canlet.2025.217441_bib209","first-page":"209","article-title":"Lymphocyte trafficking and regional immunity","volume":"vol. 72","author":"Butcher","year":"1999"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217441_bib211","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00491","article-title":"High endothelial venules and lymphatic vessels in tertiary lymphoid organs: characteristics, functions, and regulation","volume":"7","author":"Ruddle","year":"2016","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib212","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2015-02-626291","article-title":"L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo","volume":"126","author":"Lafouresse","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canlet.2025.217441_bib213","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"Mcever","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib214","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10719-008-9167-z","article-title":"Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicity","volume":"26","author":"Radhakrishnan","year":"2009","journal-title":"Glycoconj. J."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib215","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular niches controlling B lymphocyte behavior within bone marrow during development","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib216","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217441_bib217","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","article-title":"Serum levels of IL-6 and TNF-\u03b1 correlate with clinicopathological features and patient survival in patients with prostate cancer","volume":"90","author":"Michalaki","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib218","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"Deberardinis","year":"2016","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib219","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4626-9","article-title":"Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers","volume":"18","author":"Aiderus","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102438","article-title":"BRCA1 induces major energetic metabolism reprogramming in breast cancer cells","volume":"9","author":"Privat","year":"2014","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.canlet.2025.217441_bib221","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1158\/0008-5472.CAN-19-1405","article-title":"BRCA1 deficiency upregulates NNMT, which reprograms metabolism and sensitizes ovarian cancer cells to mitochondrial metabolic targeting agents","volume":"79","author":"Kanakkanthara","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217441_bib222","article-title":"Metabolic requirements of the metastatic cascade","volume":"28","author":"Drapela","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"39","key":"10.1016\/j.canlet.2025.217441_bib223","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1038\/s41388-020-01432-7","article-title":"Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications","volume":"39","author":"Wei","year":"2020","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib224","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-18-1147","article-title":"Lipid uptake is an androgen-enhanced lipid supply pathway associated with prostate cancer disease progression and bone metastasis","volume":"17","author":"Tousignant","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib225","article-title":"Metabolic alterations in cancer cells and the emerging role of oncometabolites as drivers of neoplastic change","volume":"7","author":"Zhou","year":"2018","journal-title":"Antioxidants [Internet]"},{"issue":"41","key":"10.1016\/j.canlet.2025.217441_bib226","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity \u2014 United States, 2001\u20132017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"7","key":"10.1016\/j.canlet.2025.217441_bib227","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.leukres.2011.12.020","article-title":"Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies","volume":"36","author":"Castillo","year":"2012","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib228","first-page":"489","article-title":"Lifestyle factors and the risk of adult leukemia in Canada","volume":"16","author":"Kasim","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib229","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/annonc\/mdw072","article-title":"Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia","volume":"27","author":"Falchi","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jha2.366","article-title":"Second primary malignancies in chronic lymphocytic leukaemia: skin, solid organ, haematological and Richter's syndrome","volume":"3","author":"Shen","year":"2022","journal-title":"eJHaem"},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib231","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217441_bib232","doi-asserted-by":"crossref","first-page":"622","DOI":"10.6004\/jnccn.2022.0031","article-title":"NCCN guidelines\u00ae insights: chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 3.2022","volume":"20","author":"Wierda","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.canlet.2025.217441_bib233","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.2147\/OTT.S245848","article-title":"Bruton's tyrosine kinase (BTK) inhibitor (Ibrutinib)-suppressed migration and invasion of prostate cancer","volume":"13","author":"Zhu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"6_suppl","key":"10.1016\/j.canlet.2025.217441_bib234","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1200\/JCO.2023.41.6_suppl.182","article-title":"Phase Ib trial of enzalutamide (Enza) with venetoclax (Ven) in metastatic castration-resistant prostate cancer (mCRPC)","volume":"41","author":"Perimbeti","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.33696\/Nanotechnol.5.048","article-title":"The effect of nano-encapsulated orlistat on prostate cancer: an in vitro study","volume":"5","author":"Armutcu","year":"2024","journal-title":"Journal of Nanotechnology and Nanomaterials"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib236","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204203","article-title":"Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model","volume":"41","author":"Tyan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib237","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjh.14119","article-title":"SphK1 inhibitor potentiates the anti\u2010cancer effect of EGCG on leukaemia cells","volume":"178","author":"Tsukamoto","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2025.217441_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143881","article-title":"Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia","volume":"13","author":"Sarapura Martinez","year":"2023","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2025.217441_bib239","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/jnci\/92.23.1897","article-title":"Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism","volume":"92","author":"Maurer","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canlet.2025.217441_bib240","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-017-0039-2","article-title":"Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition","volume":"8","author":"Galicia-V\u00e1zquez","year":"2018","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib241","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11307-014-0814-4","article-title":"Inhibition of lipid oxidation increases glucose metabolism and enhances 2-deoxy-2-[18F]fluoro-d-glucose uptake in prostate cancer mouse xenografts","volume":"17","author":"Schlaepfer","year":"2015","journal-title":"Mol. Imag. Biol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib242","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/or.2013.2301","article-title":"Promising anti-leukemic activity of atorvastatin","volume":"29","author":"\u017bo\u0142nierczyk","year":"2013","journal-title":"Oncol. Rep."},{"issue":"26","key":"10.1016\/j.canlet.2025.217441_bib243","doi-asserted-by":"crossref","first-page":"22624","DOI":"10.18632\/oncotarget.4168","article-title":"Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells","volume":"6","author":"Bruno","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib244","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bju.15851","article-title":"Phase II proof\u2010of\u2010concept study of atorvastatin in castration\u2010resistant prostate cancer","volume":"131","author":"Rushworth","year":"2023","journal-title":"BJU Int."},{"key":"10.1016\/j.canlet.2025.217441_bib245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2018.11.032","article-title":"Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy","volume":"112","author":"Wu","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2025.217441_bib246","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2012.12.004","article-title":"Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality","volume":"63","author":"Spratt","year":"2013","journal-title":"Eur. Urol."},{"issue":"23","key":"10.1016\/j.canlet.2025.217441_bib247","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2025.217441_bib248","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo","volume":"119","author":"Ponader","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.canlet.2025.217441_bib249","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.canlet.2025.217441_bib250","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","article-title":"Lipid catabolism via CPT1 as a therapeutic target for prostate cancer","volume":"13","author":"Schlaepfer","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"43","key":"10.1016\/j.canlet.2025.217441_bib251","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/onc.2016.103","article-title":"Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline","volume":"35","author":"Liu","year":"2016","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.canlet.2025.217441_bib252","doi-asserted-by":"crossref","first-page":"38264","DOI":"10.18632\/oncotarget.16123","article-title":"Lipid degradation promotes prostate cancer cell survival","volume":"8","author":"Itkonen","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.canlet.2025.217441_bib253","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00277-010-0988-z","article-title":"Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells","volume":"89","author":"Podhorecka","year":"2010","journal-title":"Ann. Hematol."},{"issue":"19","key":"10.1016\/j.canlet.2025.217441_bib254","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.3390\/cancers14194792","article-title":"Modulation of plasma lipidomic profiles in metastatic castration-resistant prostate cancer by simvastatin","volume":"14","author":"Mak","year":"2022","journal-title":"Cancers"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:00:00Z","timestamp":1760742000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":253,"alternative-id":["S0304383525000059"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217441","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217441"}}